Skip to main content

Tracheal Intubation Morbidity

0
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Eppendorf
EppendorfGermany - Hamburg
1 program
nasotracheal intubationN/A1 trial
Active Trials
NCT05780385Completed126Est. Nov 2024
KARL STORZ Endoscopy
KARL STORZ EndoscopyCA - El Segundo
1 program
timed intubationN/A1 trial
Active Trials
NCT01215422Completed646Est. Jul 2011
Verathon
VerathonBC - Burnaby
1 program
timed intubationN/A

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Eppendorfnasotracheal intubation
KARL STORZ Endoscopytimed intubation

Clinical Trials (2)

Total enrollment: 772 patients across 2 trials

NCT05780385Eppendorfnasotracheal intubation

Nasotracheal Intubation in Critically Ill.

Start: Feb 2023Est. completion: Nov 2024126 patients
N/ACompleted

Success of Pediatric Anesthesiologists in Learning to Use Videolaryngoscopes

Start: Jan 2007Est. completion: Jul 2011646 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.